Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
2016 ◽
pp. 217-225
2008 ◽
Vol 395
(1-2)
◽
pp. 120-123
◽
2017 ◽
Vol 94
(3)
◽
pp. 520-526
◽
2002 ◽
Vol 11
(2)
◽
pp. 349-357
◽
2006 ◽
Vol 12
(8)
◽
pp. 2434-2441
◽